BNP Paribas Financial Markets’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.2M | Buy |
|
|||||
|
2025
Q2 | $19M | Buy |
|
|||||
|
2025
Q1 | $10.9M | Buy |
|
|||||
|
2024
Q4 | $692K | Sell |
|
|||||
|
2024
Q3 | $968K | Buy |
|
|||||
|
2024
Q2 | $337K | Sell |
|
|||||
|
2024
Q1 | $4.27M | Buy |
|
|||||
|
2023
Q4 | $5.14M | Sell |
|
|||||
|
2023
Q3 | $3.93M | Buy |
|
|||||
|
2023
Q2 | $1.84M | Sell |
|
|||||
|
2023
Q1 | $1.9M | Sell |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.18M | Sell |
|
|||||
|
2022
Q1 | $2.51M | Buy |
|
|||||
|
2021
Q4 | $439K | Buy |
|
|||||
|
2021
Q3 | $1.08M | Buy |
|
|||||
|
2021
Q2 | $387K | Sell |
|
|||||
|
2021
Q1 | $892K | Buy |
|
|||||
|
2020
Q4 | $795K | Sell |
|
|||||
|
2020
Q3 | $643K | Buy |
|
|||||
|
2020
Q2 | $283K | Sell |
|
|||||
|
2020
Q1 | $746K | Buy |
|
|||||
|
2019
Q4 | $114K | Sell |
|
|||||
|
2019
Q3 | $70.8K | Buy |
|